Yushan Siriwardhana, Gürkan Gür, Mika Ylianttila, Madhusanka Liyanage, The role of 5G for digital healthcare against COVID-19 pandemic: Opportunities and challenges, ICT Express, 2020, , ISSN 2405-9595, https://doi.org/10.1016/j.icte.2020.10.002
The role of 5G for digital healthcare against COVID-19 pandemic : opportunities and challenges
|Author:||Siriwardhana, Yushan1; Gür, Gürkan2; Ylianttila, Mika1;|
1Centre for Wireless Communications, University of Oulu, Pentti Kaiteran katu 1, 90570, Oulu, Finland
2Zurich University of Applied Sciences (ZHAW), Gertrudstrasse 15, 8400 Winterthur, Switzerland
|Online Access:||PDF Full Text (PDF, 1.9 MB)|
|Persistent link:|| http://urn.fi/urn:nbn:fi-fe2020120299057
|Publish Date:|| 2020-12-02
COVID-19 pandemic caused a massive impact on healthcare, social life, and economies on a global scale. Apparently, technology has a vital role to enable ubiquitous and accessible digital health services in pandemic conditions as well as against “re-emergence” of COVID-19 disease in a post-pandemic era. Accordingly, 5G systems and 5G-enabled e-health solutions are paramount. This paper highlights methodologies to effectively utilize 5G for e-health use cases and its role to enable relevant digital services. It also provides a comprehensive discussion of the implementation issues, possible remedies and future research directions for 5G to alleviate the health challenges related to COVID-19.
|Pages:||1 - 9|
|Type of Publication:||
A1 Journal article – refereed
|Field of Science:||
213 Electronic, automation and communications engineering, electronics
This work is partly supported by the European Union in RESPONSE 5G (Grant No: 789658) project and the Academy of Finland in 6Genesis (Grant No. 318927) and 5GEAR (Grant No. 319669) projects.
|Academy of Finland Grant Number:||
318927 (Academy of Finland Funding decision)
319669 (Academy of Finland Funding decision)
© 2020 The Korean Institute of Communications and Information Sciences (KICS). Publishing services by Elsevier B.V. his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).